CORC

浏览/检索结果: 共541条,第1-10条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
The effects of centroid anisoplanatism on measuring and mitigating tip-tilt disturbance 会议论文
Beijing, China, December 3, 2019 - December 5, 2019
作者:  Zeng, Fengjiao;  Yang, Kangjian;  Wen, Lianghua;  Yang, Ping;  Wang, Shuai
收藏  |  浏览/下载:5/0  |  提交时间:2021/05/11
A 3D Deep Residual Convolutional Neural Network for Differential Diagnosis of Parkinsonian Syndromes on F-18-FDG PET Images 会议论文
作者:  Yakushev, Igor;  Weber, Wolfgang;  Schwaiger, Markus;  Cumming, Paul;  Huang, Sung-Cheng
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/05
Correlations between dopammergic dysfunction and abnormal metabolic network activity in REM sleep behavior disorder 会议论文
作者:  Zuo, Chuantao;  Wu, Ping;  Yu, Huan;  Huang, Zhemin;  Jiang, Chengfeng
收藏  |  浏览/下载:10/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:45/0  |  提交时间:2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载:34/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:36/0  |  提交时间:2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载:32/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:29/0  |  提交时间:2019/12/05
MOLECULAR CHARACTERIZATION AND STRATIFICATION OF IDIOPATHIC INFLAMMATORY MYOPATHIES: ON THE BASIS OF SKELETAL MUSCLE TRANSCRIPTOME STUDY 会议论文
ANNALS OF THE RHEUMATIC DISEASES, 2019-06-01
作者:  Chen, He;  Lu, Xin;  Shang, Jing-Zhe;  Wu, Ai-Ping;  Cheng, Gen-Hong
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/03
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace